Literature DB >> 1996

Search for herpetic antibodies in the cerebrospinal fluid in senile dementia and mental retardation.

H Libíková, J Pogády, V Wiedermann, S Breier.   

Abstract

Complement-requiring neutralizing antibodies to herpes simplex type 1 virus (HSV 1) in titres from 2 to greater than 16 were detected in the cerebrospinal fluid (CSF) of 47% senile patients with various forms of dementia, but in none of mentally retarded adolescents and adults suffering from various neurologidal diseases. Also the incidence of HSV 1 serum antibodies in elevated titres (larger than or equal to 512) was increased in senile demented patients (61%) as compared with persons in normal senium (31%), normal adults (15%), mentally retarded adolescents (17%) and prisoned felons with low IQ (45-47%).

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1996

Source DB:  PubMed          Journal:  Acta Virol        ISSN: 0001-723X            Impact factor:   1.162


  5 in total

1.  Viruses, Parkinsonism and Alzheimer's disease.

Authors:  D M Mann; P O Yates; J S Davies; J Hawkes
Journal:  J Neurol Neurosurg Psychiatry       Date:  1981-07       Impact factor: 10.154

Review 2.  NF-κB and STAT3 signaling pathways collaboratively link inflammation to cancer.

Authors:  Yihui Fan; Renfang Mao; Jianhua Yang
Journal:  Protein Cell       Date:  2013-03-13       Impact factor: 14.870

3.  Neurological disease and herpes simplex virus. An immunohistochemical study.

Authors:  D M Mann; A M Tinkler; P O Yates
Journal:  Acta Neuropathol       Date:  1983       Impact factor: 17.088

Review 4.  Possible factors in the etiology of Alzheimer's disease.

Authors:  R F Itzhaki
Journal:  Mol Neurobiol       Date:  1994 Aug-Dec       Impact factor: 5.590

5.  Blubber cortisol: a potential tool for assessing stress response in free-ranging dolphins without effects due to sampling.

Authors:  Nicholas M Kellar; Krista N Catelani; Michelle N Robbins; Marisa L Trego; Camryn D Allen; Kerri Danil; Susan J Chivers
Journal:  PLoS One       Date:  2015-02-02       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.